Pages that link to "Q42450193"

The following pages link to The activation of cannabinoid receptors in striatonigral GABAergic neurons inhibited GABA uptake. (Q42450193):

Displaying 39 items.

• The neurobiology and evolution of cannabinoid signalling (Q24522320) (← links)
• The effects of cannabinoids on the brain (Q28137626) (← links)
• Fine motor control in rats is disrupted by delta-9-tetrahydrocannabinol (Q28145410) (← links)
• Increased cannabinoid CB1 receptor binding and activation of GTP-binding proteins in the basal ganglia of patients with Parkinson's syndrome and of MPTP-treated marmosets (Q28203208) (← links)
• Presynaptic mechanisms underlying cannabinoid inhibition of excitatory synaptic transmission in rat striatal neurons (Q28363375) (← links)
• Pre- and postsynaptic localization of GABA(B) receptors in the basal ganglia in monkeys (Q30830239) (← links)
• Cannabinoids, endogenous ligands and synthetic analogs (Q33695713) (← links)
• Effects of nefiracetam on spatial memory function and acetylcholine and GABA metabolism in microsphere-embolized rats (Q34155664) (← links)
• Cannabinoid modulation of the dopaminergic circuitry: implications for limbic and striatal output (Q34248777) (← links)
• The decrease of dopamine D₂/D₃ receptor densities in the putamen and nucleus caudatus goes parallel with maintained levels of CB₁ cannabinoid receptors in Parkinson's disease: a preliminary autoradiographic study with the selective dopamine D₂/D (Q34267133) (← links)
• Hu 210: a potent tool for investigations of the cannabinoid system. (Q34320139) (← links)
• Changes in cannabinoid CB(1) receptors in striatal and cortical regions of rats with experimental allergic encephalomyelitis, an animal model of multiple sclerosis (Q34515581) (← links)
• Cannabis and cannabinoid receptors: from pathophysiology to therapeutic options (Q34549222) (← links)
• CB1-independent inhibition of dopamine transporter activity by cannabinoids in mouse dorsal striatum (Q34605794) (← links)
• Functions of cannabinoid receptors in the hippocampus (Q34750566) (← links)
• The endogenous cannabinoid system and the basal ganglia. biochemical, pharmacological, and therapeutic aspects. (Q34786832) (← links)
• Separate and combined effects of the GABA reuptake inhibitor tiagabine and Δ9-THC in humans discriminating Δ9-THC. (Q35840095) (← links)
• The inhibitory effect of anandamide on luteinizing hormone-releasing hormone secretion is reversed by estrogen (Q37416382) (← links)
• Modulation of the release of endogenous gamma-aminobutyric acid by cannabinoids in the guinea pig ileum (Q39122422) (← links)
• Cannabinoid receptor and WIN-55,212-2-stimulated [35S]GTP gamma S binding and cannabinoid receptor mRNA levels in the basal ganglia and the cerebellum of adult male rats chronically exposed to delta 9-tetrahydrocannabinol (Q42469712) (← links)
• Perinatal delta9-tetrahydrocannabinol exposure augmented the magnitude of motor inhibition caused by GABA(B), but not GABA(A), receptor agonists in adult rats. (Q42474019) (← links)
• Unilateral 6-hydroxydopamine lesions of nigrostriatal dopaminergic neurons increased CB1 receptor mRNA levels in the caudate-putamen (Q42487505) (← links)
• Cannabinoid receptor messenger RNA levels decrease in a subset of neurons of the lateral striatum, cortex and hippocampus of transgenic Huntington's disease mice (Q42490465) (← links)
• Alleviation of motor hyperactivity and neurochemical deficits by endocannabinoid uptake inhibition in a rat model of Huntington's disease. (Q42517324) (← links)
• Effects of cannabinoids on prolactin and gonadotrophin secretion: involvement of changes in hypothalamic gamma-aminobutyric acid (GABA) inputs (Q42538098) (← links)
• Effects of cannabinoid CB1 receptor agonism and antagonism on SKF81297-induced dyskinesia and haloperidol-induced dystonia in Cebus apella monkeys (Q42844506) (← links)
• Evaluation of the role of striatal cannabinoid CB1 receptors on movement activity of parkinsonian rats induced by reserpine (Q43064653) (← links)
• Effects of CB1 cannabinoid receptor blockade on ethanol preference after chronic ethanol administration (Q43754879) (← links)
• Protective effects of cannabinoid receptor agonists against cocaine and other convulsant-induced toxic behavioural symptoms (Q43815277) (← links)
• Delta(9)-THC-induced cognitive deficits in mice are reversed by the GABA(A) antagonist bicuculline (Q45025701) (← links)
• Loss of mRNA levels, binding and activation of GTP-binding proteins for cannabinoid CB1 receptors in the basal ganglia of a transgenic model of Huntington's disease (Q45305400) (← links)
• Manipulation of fatty acid amide hydrolase functional activity alters sensitivity and dependence to ethanol (Q46943485) (← links)
• Extrapyramidal and neuroendocrine effects of AM404, an inhibitor of the carrier-mediated transport of anandamide (Q48136699) (← links)
• Finding of the endocannabinoid signalling system in Hydra, a very primitive organism: possible role in the feeding response (Q48171307) (← links)
• Decreased GABAA and GABAB receptor functional activity in cannabinoid CB1 receptor knockout mice (Q48315314) (← links)
• Cannabinoid CB1 receptors activation and coactivation with D2 receptors modulate GABAergic neurotransmission in the globus pallidus and increase motor asymmetry (Q48407695) (← links)
• The effects of acute treatment with delta9-THC on exploratory behaviour and memory in the rat. (Q52167130) (← links)
• Immunocytochemical localization of cannabinoid CB1 receptor and fatty acid amide hydrolase in rat retina (Q73129294) (← links)
• Influence of tiagabine maintenance on cannabis effects and related behaviors in daily cannabis users (Q88971676) (← links)